These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7118066)

  • 1. Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyldisulfide, and octanoic acid.
    Zeneroli ML; Ventura E; Baraldi M; Penne A; Messori E; Zieve L
    Hepatology; 1982; 2(5):532-8. PubMed ID: 7118066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins.
    Pappas SC; Ferenci P; Schafer DF; Jones EA
    Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure].
    Jones EA; Ferenci P; Pappas SC; Schafer DF
    Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual evoked potentials in a rabbit model of hepatic encephalopathy. I. Sequential changes and comparisons with drug-induced comas.
    Schafer DF; Pappas SC; Brody LE; Jacobs R; Jones EA
    Gastroenterology; 1984 Mar; 86(3):540-5. PubMed ID: 6693015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic encephalopathy. Application of visual evoked responses to test hypotheses of its pathogenesis in rats.
    Jones DB; Mullen KD; Roessle M; Maynard T; Jones EA
    J Hepatol; 1987 Feb; 4(1):118-26. PubMed ID: 3033057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids.
    Baraldi M; Pinelli G; Ricci P; Zeneroli ML
    Arch Toxicol Suppl; 1984; 7():103-5. PubMed ID: 6097201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increase in cerebral benzodiazepine receptors induced by a subacute administration of ammonia, mercaptans and short-chain fatty acids in rats.
    Baraldi M; Zeneroli ML; Ventura E; Vezzelli C
    Clin Sci (Lond); 1987 Dec; 73(6):669-71. PubMed ID: 2826071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hepatic failure toxins on regenerative enzymes in the liver after injury with galactosamine in the rat.
    Zieve L; Dozeman R
    J Lab Clin Med; 1989 Apr; 113(4):463-8. PubMed ID: 2703758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure.
    Zeneroli ML
    J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands.
    Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA
    Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist.
    Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M
    Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.
    Zeneroli ML; Pinelli G; Gollini G; Penne A; Messori E; Zani G; Ventura E
    Gut; 1984 Mar; 25(3):291-9. PubMed ID: 6421664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain methanethiol and ammonia concentrations in experimental hepatic coma and coma induced by injections of various combinations of these substances.
    Zieve L; Doizaki WM; Lyftogt C
    J Lab Clin Med; 1984 Nov; 104(5):655-64. PubMed ID: 6491466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Middle molecules in the serum, brain, liver and urine of galactosamine-induced fulminant hepatic failure rats.
    Shu CD; Chang TM
    Int J Artif Organs; 1983 Sep; 6(5):273-7. PubMed ID: 6642726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials.
    Kullmann F; Hollerbach S; Holstege A; Schölmerich J
    J Hepatol; 1995 Jan; 22(1):101-10. PubMed ID: 7751576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Decreased dopaminergic activity in hepatic encephalopathy in rats with galactosamine-induced acute liver failure].
    Yamada A; Takeuchi H; Miki H; Touge T; Nishioka M
    No To Shinkei; 1992 Feb; 44(2):103-9. PubMed ID: 1567728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in free radicals, trace elements, and neurophysiological function in rats with liver damage induced by D-galactosamine.
    Hu HL; Chen RD
    Biol Trace Elem Res; 1992 Jul; 34(1):19-25. PubMed ID: 1382518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of visual evoked potentials in experimental hepatic encephalopathy and in pharmacologically induced coma-like states in rat.
    Zeneroli ML; Penne A; Parrinello G; Cremonini C; Ventura E
    Life Sci; 1981 Mar; 28(13):1507-15. PubMed ID: 7242244
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a single, short intravenous dose of acetyl-L-carnitine on pattern-reversal visual-evoked potentials in cirrhotic patients with hepatic encephalopathy.
    Siciliano M; Annicchiarico BE; Lucchese F; Bombardieri G
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):76-80. PubMed ID: 16445703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential toxins of acute liver failure and their effects on blood-brain barrier permeability.
    Zaki AE; Wardle EN; Canalese J; Ede RJ; Williams R
    Experientia; 1983 Sep; 39(9):988-91. PubMed ID: 6884496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.